Skip to main content

Table 3 Comparison of initial antimicrobial agents use in patients with non-ventilator and ventilator-associated hospital-acquired pneumonia

From: Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?

Main agents used Group, n (%) pValue
Non-ventilator associated (n = 48) Ventilator-associated (n = 96)
Anti-pseudomonal penicillinsa 5 (10.4) 10 (10.4) 1.000
Anti-pseudomonal cephalosporinsb 12 (25.0) 18 (18.8) 0.514
Anti-pseudomonal fluoroquinolonesc 4 (8.3) 4 (4.2) 0.441
Anti-pseudomonal carbapenemsd 14 (29.2) 29 (30.2) 1.000
Ampicillin/sulbactam or sulbactam 5 (10.4) 13 (13.5) 0.789
Non-anti-pseudomonal β-lactamasee 6 (12.5) 16 (16.7) 0.682
Miscellaneousf 2 (4.2) 6 (6.3) 0.719
  1. aIncluding piperacillin, piperacillin/tazobactam, and ticarcillin/clavulanate.
  2. bIncluding cefoperazone, ceftazidime, cefepime, and cefpirome.
  3. cIncluding ciprofloxacin and levofloxacin.
  4. dIncluding imipenem and meropenem.
  5. eIncluding penicillin, amoxicillin/clavulanate, cefazolin, cefuroxime, cefotaxime, cefmetazole, and flomoxef.
  6. fIncluding teicoplanin or clindamycin plus amikacin.